Manufacturing news briefs – stories you might have missed

Cell Therapies to manufacture Kymriah Melbourne contract manufacturer Cell Therapies has been given Therapeutic Goods Administration approval to manufacture Novartis’ chimeric antigen receptor T-cell at its facility at the Peter MacCallum Cancer Centre. The one-off treatment for blood cancers involves removing cells from the patient, reprogramming them and infuysing them back into the body. The…

Cochlear recovers as hospital surgeries resume

Hearing implant manufacturer Cochlear is recovering from the effects of the Covid-19 pandemic which interrupted surgical procedures, reporting today half-year earnings before interest and tax (EBIT) down only four per cent on the previous corresponding period. The Sydney company reported EBIT of $175.6 million with 17,377 implant units sold in the half compared to 18,894…